Literature DB >> 16140489

Changes in P2Y2 receptor localization on adrenaline- and noradrenaline-containing chromaffin cells in the rat adrenal gland during development and aging.

Mekbeb Afework1, Geoffrey Burnstock.   

Abstract

Using immunohistochemistry, the occurrence and age-related changes of the P2Y2 receptor was investigated in the adrenal gland of rat at different ages, ranging from embryonic day E16 to 22 months. Immunoreactivity for the P2Y2 receptor was present in chromaffin cells and nerve fibres at all ages examined. Double labeling with the antibody against phenyl ethanolamine-N-methyltransferase, which marks adrenaline-producing chromaffin cells, revealed that only a few of the P2Y2-immunoreactive cells were adrenaline producing at embryonic day E16, the vast majority being noradrenaline-containing cells. However, immunoreactivity for adrenaline-containing cells in the P2Y2 receptor-labeled chromaffin cells increased with increasing age and at 1 week post-natal almost all chromaffin cells were positive for both P2Y2 and phenyl ethanolamine-N-methyltransferase, while noradrenaline-containing cells were minimal. At 2 weeks, there was a dramatic drop in P2Y2-immunoreactive chromaffin cells and this was maintained in adult rats, noradrenaline-containing cells dominating. In the aging rat adrenals, P2Y2 receptor-immunoreactivity was localized in subpopulations of both adrenaline and noradrenaline-producing cells. Intrinsic neurones were also visible that were positively labeled with the P2Y2 receptor antibody in the adrenals of both adult and aging rats. P2Y2-immunoreactive nerve fibres formed a plexus around the adrenal cortical cells of zona glomerulosa in the post-natal, but not in adult or aging rats. In conclusion, this study suggests that ATP, acting through P2Y2 receptors, may influence the phenotypic expression of chromaffin cells during the development and aging of the rat adrenal gland. However, during early development, when the chromaffin cells are actively dividing and during aging, when the adrenal medullary cells are known to show hyperplastic lesions, ATP acting through P2Y2 receptors may be involved in other physiological activities, such as proliferation and/or differentiation of the chromaffin cells associated with their adrenaline or noradrenaline phenotype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16140489     DOI: 10.1016/j.ijdevneu.2005.07.004

Source DB:  PubMed          Journal:  Int J Dev Neurosci        ISSN: 0736-5748            Impact factor:   2.457


  6 in total

1.  Selective catecholamine recognition with NeuroSensor 521: a fluorescent sensor for the visualization of norepinephrine in fixed and live cells.

Authors:  Kenneth S Hettie; Xin Liu; Kevin D Gillis; Timothy E Glass
Journal:  ACS Chem Neurosci       Date:  2013-03-25       Impact factor: 4.418

2.  Expression of the P2Y₂ receptor on the rat ocular surface during a 1-year rearing period.

Authors:  Hidetoshi Tanioka; Yumi Kuriki; Asuka Sakamoto; Osamu Katsuta; Kouichi Kawazu; Masatsugu Nakamura
Journal:  Jpn J Ophthalmol       Date:  2014-09-02       Impact factor: 2.447

Review 3.  Purinergic signalling in endocrine organs.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

Review 4.  Purinergic signalling during development and ageing.

Authors:  Geoffrey Burnstock; Nicholas Dale
Journal:  Purinergic Signal       Date:  2015-05-20       Impact factor: 3.765

5.  Impairment of vesicular ATP release affects glucose metabolism and increases insulin sensitivity.

Authors:  Shohei Sakamoto; Takaaki Miyaji; Miki Hiasa; Reiko Ichikawa; Akira Uematsu; Ken Iwatsuki; Atsushi Shibata; Hisayuki Uneyama; Ryoichi Takayanagi; Akitsugu Yamamoto; Hiroshi Omote; Masatoshi Nomura; Yoshinori Moriyama
Journal:  Sci Rep       Date:  2014-10-21       Impact factor: 4.379

6.  Functional distribution of Ca2+-coupled P2 purinergic receptors among adrenergic and noradrenergic bovine adrenal chromaffin cells.

Authors:  Angelo R Tomé; Enrique Castro; Rosa M Santos; Luís M Rosário
Journal:  BMC Neurosci       Date:  2007-06-14       Impact factor: 3.288

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.